Literature DB >> 19492216

Buprenorphine for opioid dependence.

Megan Milne1, Barbara Insley Crouch, E Martin Caravati.   

Abstract

Buprenorphine is a partial mu agonist opioid that is FDA-approved to manage opioid addiction in settings outside of traditional methadone clinics. The clinical uses, pharmacokinetics, pharmacodynamics, toxicology, and management of overdoses of buprenorphine are reviewed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19492216     DOI: 10.1080/15360280902900869

Source DB:  PubMed          Journal:  J Pain Palliat Care Pharmacother        ISSN: 1536-0288


  3 in total

1.  Intravenous misuse of buprenorphine: characteristics and extent among patients undergoing drug maintenance therapy.

Authors:  Enrico Moratti; Hamid Kashanpour; Tiziana Lombardelli; Maria Maisto
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

Review 2.  The Black Book of Psychotropic Dosing and Monitoring.

Authors:  Alan F Schatzberg; DeBattista Charles
Journal:  Psychopharmacol Bull       Date:  2018-01-15

3.  Differential activation of pregnane X receptor and constitutive androstane receptor by buprenorphine in primary human hepatocytes and HepG2 cells.

Authors:  Linhao Li; Hazem E Hassan; Antonia H Tolson; Stephen S Ferguson; Natalie D Eddington; Hongbing Wang
Journal:  J Pharmacol Exp Ther       Date:  2010-09-09       Impact factor: 4.030

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.